{
    "clinical_study": {
        "@rank": "33503", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Standard treatment"
            }, 
            {
                "arm_group_label": "Intervention", 
                "arm_group_type": "Experimental", 
                "description": "Endometrial biopsy before standard treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate the potential benefits in implantation, clinical\n      pregnancy and live birth rates by an endometrial biopsy prior to an IVF/ICSI treatment.\n      Including a follow up on possible pregnancy complications and data on children at birth.\n\n      Further it is planned to aspirate secretions from the uterus and take blood samples during\n      the treatment, which presumably can provide information about the mechanisms underlying the\n      possible effect of the treatment."
        }, 
        "brief_title": "Therapeutic Endometrial Biopsy", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Infertility", 
            "Endometrium", 
            "ART", 
            "Endometrial Biopsy"
        ], 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "detailed_description": {
            "textblock": "Randomized controlled prospective clinical study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  One or more previous failed implantation despite transfer of good            quality\n             embryons/blastocyst in a fresh IVF/ICSI treatment\n\n          -  Planned Antagonist treatment\n\n          -  Planned Standardized hormone treatment\n\n          -  FSH: 2-12 IU/L\n\n          -  Age: 18-40 years\n\n          -  BMI: 18-32\n\n          -  Regular menstrual cycles\n\n          -  Written consent\n\n        Exclusion Criteria:\n\n          -  Patients in need for a interpreter\n\n          -  Suspected intrauterine abnormalities ( fibromes, polyps, adenomyosis, sactosalpinges)\n\n          -  Planned use og Assisted hatching or use of specialized media\n\n          -  Previous inclusion in the study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963819", 
            "org_study_id": "Miacol-2013-1H"
        }, 
        "intervention": {
            "arm_group_label": "Intervention", 
            "description": "The endometrial biopsy will be done in the luteal phase (cycle day 18-22) prior to the treatment cycle (antagonist)", 
            "intervention_name": "Endometrial biopsy", 
            "intervention_type": "Other", 
            "other_name": [
                "Endometrial scratching", 
                "Endometrial injury", 
                "Local injury to the endometrium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 27, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Dronninglund", 
                        "country": "Denmark"
                    }, 
                    "name": "Fertility Clinic, Dronninglund Hospital (Aalborg University Hospital)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "miaolsen@rm.dk", 
                    "last_name": "Mia Steengaard Olesen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Horsens", 
                        "country": "Denmark"
                    }, 
                    "name": "Fertility Clinic, Horsens Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skive", 
                        "country": "Denmark"
                    }, 
                    "name": "Fertility Clinic, Skive Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "other_outcome": [
            {
                "description": "Placenta abnormalities, pregnancy related hypetensive disorders, IUGR, GDM", 
                "measure": "Rate of pregnancy complications", 
                "safety_issue": "No", 
                "time_frame": "Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years."
            }, 
            {
                "description": "Gestationel age, Preterm birth, LGA/SGA/NGA, Gender, Placenta abnormalities", 
                "measure": "Data on children and placenta at birth", 
                "safety_issue": "No", 
                "time_frame": "Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years."
            }
        ], 
        "overall_contact": {
            "email": "miaolsen@rm.dk", 
            "last_name": "Mia Steengaard Olesen, MD", 
            "phone": "+4578426562"
        }, 
        "overall_contact_backup": {
            "email": "axel.forman@ki.au.dk", 
            "last_name": "Axel Forman, MD, DMsc"
        }, 
        "overall_official": [
            {
                "affiliation": "Departement of Gynaecology and Obstetrics, Aarhus University Hospital, Skejby", 
                "last_name": "Axel Forman, MD, DMsc", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Fertility Clinic, Horsens Hospital", 
                "last_name": "Inge E Agerholm, M.Sc, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fertility Clinic, Horsens Hospital", 
                "last_name": "Benedicte Hauge, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fertility Clinic, Skive Hospital", 
                "last_name": "Peter Humaidan, MD, DMSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fertility Clinic Horsens Hospital, Aarhus University", 
                "last_name": "Mia Steengaard Olesen, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of clinical pregnancy", 
            "safety_issue": "No", 
            "time_frame": "Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963819"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Rate of biochemical pregnancy", 
                "safety_issue": "No", 
                "time_frame": "Individual outcome will be evaluated within 8 weeks after embryo transfer. Overall outcome will be evaluated after 3 years."
            }, 
            {
                "measure": "Rate of implantation", 
                "safety_issue": "No", 
                "time_frame": "Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years."
            }, 
            {
                "measure": "Rate of live birth", 
                "safety_issue": "No", 
                "time_frame": "Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years."
            }
        ], 
        "source": "University of Aarhus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}